Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis

INTRODUCTION: Radiotherapy may augment systemic antitumor responses to immunotherapy. We did a retrospective study to infer whether radiotherapy improves outcomes to immunotherapy in patients with stage III and IV non-small-cell lung cancer (NSCLC). METHODS: This retrospective study conducted at Enz...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuling, Chen, Kuifei, Yang, Meiwen, Hlaing, Swe Swe, Chen, Meng, Gu, Pinjun, Meng, Yinnan, Yang, Haihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521490/
https://www.ncbi.nlm.nih.gov/pubmed/36189277
http://dx.doi.org/10.3389/fimmu.2022.991431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521490/
https://www.ncbi.nlm.nih.gov/pubmed/36189277
http://dx.doi.org/10.3389/fimmu.2022.991431

Ejemplares similares